Last reviewed · How we verify
Patients- dose titration
Patients- dose titration is a Small molecule drug developed by Institute of Psychiatry, London. It is currently FDA-approved.
ZG0895 Hydrochloride for Injection is a small molecule being studied in a Phase 1 clinical trial for its potential efficacy in treating advanced solid tumors. The study is investigating the tolerability, safety, pharmacokinetics, and pharmacodynamics of ZG0895 Hydrochloride for Injection, with cotinine being a 15% component of the dose.
At a glance
| Generic name | Patients- dose titration |
|---|---|
| Sponsor | Institute of Psychiatry, London |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia (PHASE2)
- Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure (NA)
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure (PHASE3)
- Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome (PHASE2)
- Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients (PHASE4)
- Open Label Treprostinil Raynaud's Study (PHASE4)
- Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain (EARLY_PHASE1)
- N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Patients- dose titration CI brief — competitive landscape report
- Patients- dose titration updates RSS · CI watch RSS
- Institute of Psychiatry, London portfolio CI
Frequently asked questions about Patients- dose titration
What is Patients- dose titration?
Who makes Patients- dose titration?
What development phase is Patients- dose titration in?
Related
- Manufacturer: Institute of Psychiatry, London — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing